IT8820145A0 - Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. - Google Patents

Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Info

Publication number
IT8820145A0
IT8820145A0 IT8820145A IT2014588A IT8820145A0 IT 8820145 A0 IT8820145 A0 IT 8820145A0 IT 8820145 A IT8820145 A IT 8820145A IT 2014588 A IT2014588 A IT 2014588A IT 8820145 A0 IT8820145 A0 IT 8820145A0
Authority
IT
Italy
Prior art keywords
procedure
preparation
pharmaceutical composition
controlled release
release pharmaceutical
Prior art date
Application number
IT8820145A
Other languages
English (en)
Other versions
IT1216570B (it
Inventor
Maria Lucia Lovrecich
Original Assignee
Vectorpharma Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma Int filed Critical Vectorpharma Int
Priority to IT8820145A priority Critical patent/IT1216570B/it
Publication of IT8820145A0 publication Critical patent/IT8820145A0/it
Priority to US07/276,489 priority patent/US5008114A/en
Priority to ES88120153T priority patent/ES2042700T3/es
Priority to DE8888120153T priority patent/DE3872382T2/de
Priority to EP88120153A priority patent/EP0336014B1/en
Priority to AT88120153T priority patent/ATE77547T1/de
Application granted granted Critical
Publication of IT1216570B publication Critical patent/IT1216570B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IT8820145A 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. IT1216570B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
US07/276,489 US5008114A (en) 1988-04-08 1988-11-28 Pharmaceutical compositions with controlled release, and a method for their preparation
ES88120153T ES2042700T3 (es) 1988-04-08 1988-12-02 Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
DE8888120153T DE3872382T2 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.
EP88120153A EP0336014B1 (en) 1988-04-08 1988-12-02 Pharmaceutical compositions with controlled release, and a method for their preparation
AT88120153T ATE77547T1 (de) 1988-04-08 1988-12-02 Pharmazeutische zusammensetzungen mit verlaengerter wirkung und verfahren zu ihrer herstellung.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Publications (2)

Publication Number Publication Date
IT8820145A0 true IT8820145A0 (it) 1988-04-08
IT1216570B IT1216570B (it) 1990-03-08

Family

ID=11164167

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8820145A IT1216570B (it) 1988-04-08 1988-04-08 Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.

Country Status (6)

Country Link
US (1) US5008114A (it)
EP (1) EP0336014B1 (it)
AT (1) ATE77547T1 (it)
DE (1) DE3872382T2 (it)
ES (1) ES2042700T3 (it)
IT (1) IT1216570B (it)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290570A (en) * 1989-05-30 1994-03-01 Purepac, Inc. Lotions containing liquid-loaded powder
FR2694701B1 (fr) * 1990-04-18 1996-01-19 Biagianti Irene Application des zeolithes naturelles a l'homme et a l'environnement.
IT1243745B (it) * 1990-10-17 1994-06-21 Vectorpharma Int Composizioni terapeutiche transdermali contenenti farmaco e/o agente promotore dell'assorbimento cutaneo supportato su particelle microporose e microsfere polimeriche e loro preparazione.
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
US5409903A (en) * 1992-02-18 1995-04-25 Urecap Corporation Method and compositions for the treatment of H. pylori and dermatitis
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
WO1994007469A1 (en) * 1992-09-25 1994-04-14 Dynagen, Inc. An immunobooster for delayed release of immunogen
ATE188375T1 (de) * 1992-11-17 2000-01-15 Yoshitomi Pharmaceutical Ein antipsychotikum enthaltende mikrokugel zur verzögerten freisetzung und verfahren für ihre herstellung
NZ262562A (en) * 1993-02-23 1996-04-26 Warner Lambert Co Preparation of solvent free pharmaceutical compositions
JP3645906B2 (ja) * 1993-11-19 2005-05-11 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ マイクロカプセル封入された３−ピペリジニル−置換１，２−ベンズイソオキサゾール類及び１，２−ベンズイソチアゾール類
DE4416001C2 (de) * 1994-05-06 1997-12-11 Feinchemie Gmbh Sebnitz Komposite zur steuerbaren Wirkstoff-Freisetzung
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
US6764690B2 (en) 1996-05-29 2004-07-20 Delsitech Oy Dissolvable oxides for biological applications
DK0906243T4 (da) * 1996-05-29 2009-06-08 Delsitech Oy Oplöselige oxider til biologiske anvendelser
US7101575B2 (en) 1998-03-19 2006-09-05 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Production of nanocapsules and microcapsules by layer-wise polyelectrolyte self-assembly
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
JP4932992B2 (ja) 1999-02-22 2012-05-16 デルシテック オサケユイチア シリカゾルからの生分解性セラミック繊維
GB9904485D0 (en) * 1999-02-27 1999-04-21 Procter & Gamble Method for protecting and/or controlled release of active ingredient
DE20023081U1 (de) * 1999-06-10 2003-01-16 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 80539 München Eingekapselte Kristalle mit Mehrlagenbeschichtung
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
SK15742003A3 (sk) * 2001-06-22 2005-01-03 Pfizer Products Inc. Farmaceutická kompozícia zahrnujúca adsorbát amorfného liečiva
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
EP1469832B2 (en) * 2002-02-01 2016-10-26 Bend Research, Inc. Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
US20040132771A1 (en) * 2002-12-20 2004-07-08 Pfizer Inc Compositions of choleseteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
BRPI0413277A (pt) * 2003-08-04 2006-10-10 Pfizer Prod Inc composições farmacêuticas de adsorvatos de medicamentos amorfos e materiais que formam microfases lipofìlicas
US7387793B2 (en) * 2003-11-14 2008-06-17 Eurand, Inc. Modified release dosage forms of skeletal muscle relaxants
MY142989A (en) * 2004-03-10 2011-02-14 Bayer Schering Pharma Ag Stabilised supersaturated solids of lipophilic drugs
DE102004013637A1 (de) 2004-03-19 2005-10-13 Capsulution Nanoscience Ag Verfahren zur Herstellung von CS-Partikeln und Mikrokapseln unter Verwendung poröser Template sowie CS-Partikel und Mikrokapseln
FI20070174A0 (fi) * 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
ITMI20071930A1 (it) * 2007-10-05 2009-04-06 Sasol Italy S P A Composizioni farmaceutiche a base di zeoliti porose quali mezzi di rilascio di molecole farmacologicamente attive e relativo uso
CA2753664C (en) 2009-03-04 2019-11-05 Orexo Ab Abuse resistant formulation
DK2427177T3 (en) 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
AU2011300524B2 (en) 2010-09-07 2014-10-23 Orexo Ab A transdermal drug administration device
US9526701B2 (en) * 2011-12-20 2016-12-27 Keith R. Latham Sustained drug release and improved product stability using non-covalent particle coating methods
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
EP3125869A1 (en) * 2014-03-31 2017-02-08 Massachusetts Institute Of Technology Porous materials containing compounds including pharmaceutically active species
GB201502073D0 (en) 2015-02-09 2015-03-25 Cubic Pharmaceuticals Ltd And Delta Pharmaceuticals Ltd HDEG technology
JP7672268B2 (ja) * 2020-04-22 2025-05-07 沢井製薬株式会社 コハク酸ソリフェナシン含有コーティング粒子及びそれを含む口腔内崩壊錠

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923969A (en) * 1973-06-12 1975-12-02 Battelle Institut E V Carrier system for a drug with sustained release
US4013785A (en) * 1975-03-21 1977-03-22 Bristol-Myers Company Apap tablet containing fumed silica and process for manufacturing same
DE2845326C2 (de) * 1978-10-18 1985-05-23 Beiersdorf Ag, 2000 Hamburg Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
US4834978A (en) * 1984-10-01 1989-05-30 Biotek, Inc. Method of transdermal drug delivery
GB8606468D0 (en) * 1986-03-15 1986-04-23 Sds Biotech Uk Ltd Therapeutic compositions
US4775535A (en) * 1986-04-04 1988-10-04 Hans Lowey Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPS6327502A (ja) * 1986-07-22 1988-02-05 Agency Of Ind Science & Technol シクロデキストリン−シリカ複合体及びその製造方法

Also Published As

Publication number Publication date
EP0336014B1 (en) 1992-06-24
IT1216570B (it) 1990-03-08
ATE77547T1 (de) 1992-07-15
EP0336014A1 (en) 1989-10-11
DE3872382D1 (de) 1992-07-30
DE3872382T2 (de) 1992-12-10
ES2042700T3 (es) 1993-12-16
US5008114A (en) 1991-04-16

Similar Documents

Publication Publication Date Title
IT8820145A0 (it) Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione.
DE68901417D1 (de) Pharmazeutische zusammensetzung.
NO903001D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater med forlenget frigivelse.
GB2218905B (en) Controlled release pharmaceutical
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DK489189D0 (da) Farmaceutisk praeparat
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
IT1229562B (it) Composizioni farmaceutiche antivirali ed immunostimolanti e procedimento per la loro preparazione.
IT8919279A0 (it) Composizioni farmaceutiche contenenti un estratto vegetale e procedimento per la loro preparazione.
FI903589A7 (fi) Lääkkeitä, jotka pohjautuvat 4,1,2-1H-bentsoksadiatsiinin johdannaisiin, uusia johdannaisia ja menetelmiä niiden valmistamiseksi
DK603988D0 (da) Farmaceutisk praeparat
DK496889D0 (da) Peptidholdigt farmaceutisk praeparat
AU1888488A (en) Substituted benzimidazoles, a process for the preparation thereof, pharmaceutical formulations containing them, and theuse thereof
DK336489D0 (da) Farmaceutisk praeparat
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
GB8801863D0 (en) Pharmaceutical formulations with controlled drug release
BR9006025A (pt) Preparacao farmaceutica
ATA133288A (de) Pharmazeutische zusammensetzung
DE58905160D1 (de) Pharmazeutische zubereitung.
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
GB8911073D0 (en) New benzofuran derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same
ZA8999B (en) New indolylpieridine compounds,processes for the preparation thereof and pharmaceutical composition comprising the same
IT1224244B (it) Composizione farmaceutica anoressizzante comprendente 5-idrossitrpofano
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
DK638889D0 (da) Farmaceutisk kombinationspraeparat